Covered recipient · General Payments record
ANITALYNN ANDERSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,621.94
- Reported across 243 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $463.05 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $211.86 | 13 |
| Novo Nordisk AS | $77.59 | 4 |
| Lilly USA, LLC | $67.58 | 4 |
| GlaxoSmithKline, LLC. | $42.97 | 2 |
| Acerta Pharma LLC | $19.35 | 1 |
| PFIZER INC. | $15.91 | 1 |
| Merck Sharp & Dohme Corporation | $14.53 | 1 |
| Abbott Laboratories | $13.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.26 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125142211 | CMS |
| ABBVIE INC. | $20.09 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438887 | CMS |
| ABBVIE INC. | $17.80 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438889 | CMS |
| ABBVIE INC. | $12.38 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438891 | CMS |
| ABBVIE INC. | $12.41 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438893 | CMS |
| ABBVIE INC. | $12.87 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438895 | CMS |
| ABBVIE INC. | $20.27 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438897 | CMS |
| ABBVIE INC. | $18.14 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438899 | CMS |
| ABBVIE INC. | $17.09 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438901 | CMS |
| ABBVIE INC. | $15.72 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438903 | CMS |
| ABBVIE INC. | $18.35 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438905 | CMS |
| ABBVIE INC. | $14.25 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438907 | CMS |
| ABBVIE INC. | $13.56 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438909 | CMS |
| ABBVIE INC. | $18.93 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106438911 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.35 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105348975 | CMS |
| GlaxoSmithKline, LLC. | $17.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116690011 | CMS |
| GlaxoSmithKline, LLC. | $25.55 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116679137 | CMS |
| Lilly USA, LLC | $17.32 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135517126 | CMS |
| Lilly USA, LLC | $15.93 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135513550 | CMS |
| Lilly USA, LLC | $19.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135473041 | CMS |
| Lilly USA, LLC | $14.88 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135529203 | CMS |
| Merck Sharp & Dohme LLC | $14.53 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141947451 | CMS |
| Novo Nordisk Inc | $20.49 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100627262 | CMS |
| Novo Nordisk Inc | $19.51 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100657806 | CMS |
| Novo Nordisk Inc | $20.24 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100275446 | CMS |
| Novo Nordisk Inc | $17.35 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100616955 | CMS |
| PFIZER INC. | $15.91 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131607130 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.